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Tropomyosins were first identified in neuronal systems
in 1973. Although numerous isoforms were found and
described since then, many aspects of their function
and interactions remained unknown. Tropomyosin iso-
forms show different sorting pattern in neurogenesis.
As one example, TM5NM1/2 is present in developing
axons, but it is replaced by TMBr-3 in mature neurons,
suggesting that these tropomyosin isoforms contribute
differently to the establishment of the functional fea-
tures of the neuronal actin networks. We developed a
method for the efficient purification of TMBr-3 and
TM5NM1 as recombinant proteins using bacterial
expression system and investigated their interactions
with actin. We found that both isoforms bind actin fila-
ments, however, the binding of TM5NM1 was much
stronger than that of TMBr-3. TMBr-3 and TM5NM1
modestly affected actin assembly kinetics, in an oppo-
site manner. Consistently with the higher affinity of
TM5NM1 it inhibited actin filament disassembly more
efficiently than TMBr-3. Similarly to other previously
studied tropomyosins TM5NM1 inhibited the Arp2/3
complex-mediated actin assembly. Notably, TMBr-3 did
not influence the Arp2/3 complex-mediated polymer-
ization. This is a unique feature of TMBr-3, since so
far it is the only known tropomyosin supporting the
activity of the Arp2/3 complex, indicating that TMBr-3
may colocalize and work simultaneously with Arp2/3
complex in neuronal cells. VC 2013 Wiley Periodicals, Inc.
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Introduction
The microfilament system orchestrates a great number ofdiverse cellular processes, including the establishment
cell geometry, cell motility, intracellular transport, contrac-
tility, cytokinesis and transformation. Structurally, the basic
building blocks of microfilaments are actin and tropomyo-
sin (TM) [Vindin and Gunning, in press]. Both actin and
tropomyosin exist in several isoforms, which assemble into
distinct compartments with different molecular composi-
tion, morphology, and function [Gunning et al., 1998;
Perrin and Ervasti, 2010].
Tropomyosins are elongated, rod-shaped molecules with
extensive a-helical conformation, forming parallel-chained
coiled-coil dimers. The individual dimers assemble into hel-
ical polymers in a head-to-tail manner, cooperatively associ-
ating along the longitudinal axis of the actin filament on
both sides [Flicker et al., 1982; Coulton et al., 2008]. Tro-
pomyosins are present in all animal and fungal cells. In
mammals four tropomyosin genes are known that produce
more than 40 different mRNAs and about 25 protein iso-
forms [Gunning et al., 2005, 2008]. Traditionally, tropo-
myosin isoforms involved in the contractile apparatus of
muscle cells are referred to as muscle isoforms, while iso-
forms associated to the cell cytoskeleton are referred to as
nonmuscle or cytoskeletal tropomyosins. The expression
and localization of tropomyosin isoforms are strictly regu-
lated at both tissue and subcellular level, and often depends
on the developmental state as well [Gunning et al., 2005,
2008]. Since the first discovery of TMs in the nervous sys-
tem several neuronal isoforms have been described [Fine
et al., 1973]. The TMBr-1, 2, and 3 are encoded by the
a-TM gene [Lees-Miller et al., 1990]. TMBr-2 and 3 are
short, while TMBr-1 is a long isoform, as characterized by
the use of exon 1a and 2b or exon 1b at the N-terminus,
respectively (Fig. F11A). The g-Tm gene also encodes tropo-
myosin isoforms present in neurons, like TM5NM1 and
TM5NM2, both of them are short isoforms, carrying exon
1b (Fig. 1A). These isoforms exhibit different subcellular
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distributions and developmental profiles, as well, suggesting
their functional specialization for different neuronal processes.
TM5NM1/2 is abundantly present in early rodent
embryos at both mRNA and protein level at the site of the
axon pole in the differentiating neurons, similarly to the 7-
day old cultured primer cortical neurons [Hannan et al.,
1995]. Some days later the TM5NM1/2 proteins exhibit a






Fig. 1. (A) Exon organization of different tropomyosin isoforms. HMW: high molecular weight tropomyosins, containing exon 1a
and 2; LMW: low molecular weight tropomyosins, containing exon 1b. (B) Sequence alignment of different tropomyosin isoforms;
from top to bottom: alpha skeletal TM (Oryctolagus cuniculus), beta skeletal TM (Oryctolagus cuniculus), TMBr-3 (Mus Musculus),
TM5NM1 (Mus musculus). The sequences were aligned using ClustalX. (C) SDS-PAGE of the purified TMBr-3 and TM5NM1 pro-
teins before and after TEV protease digestion. Lane 1: MW: molecular weight marker (Fermentas).AQ5
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the 16-day rat embryo, its amount is very low at birth in
the rat cerebellum, then continuously increases until the
third postnatal week. In PC12 cells cultured on substratum
the mRNA expression of TMBr-3 highly correlated with
the induction of the neuronal morphological differentiation
[Weinberger et al., 1993]. Around the 15–17 prenatal days
the TM5NM1/2 mRNA disappears from the axon, which
coincides with the appearance of TMBr-3. The isoform
change between the TM5NM1/2 and TMBr-3 also hap-
pens at the protein level around the 17 embryonic day,
resulting in the repositioning of TM5NM1/2 into the
somatodendritic compartment of the mature neurons. Sim-
ilar results were obtained in chicken, as well, indicating that
such a switch in the isoform composition is conserved
through the evolution of the higher vertebrates [Weinberger
et al., 1996]. Further studies with more specialized antibod-
ies have demonstrated that TM5NM2 localized to the axon
shaft [Schevzov et al., 1997], while TM5NM1 to the outer
region of the growth cone in the early embryos [Schevzov
et al., 2005]. TMBr-3 was absent from the growth cones
[Schevzov et al., 1997; Had et al., 1994] and its distribu-
tion in cultured embryonic neurons was diffuse, showing
no association with specific microfilament structures
[Stamm et al., 1993]. The results also suggested that the
function of TM5NM1 and TMBr-3 was associated with
the differentiation, growth, and maintenance of the special-
ized neuronal processes. In stably transfected B35 neuroepi-
thelial cell clones overexpressing TMBr-3 very few stress
fibers, decreased cell surface and increased cell motility with
lamellipodium formation was observed. In contrast,
TM5NM1 had opposite effects on most of these processes
which was dominantly counteracted by TMBr-3 when
cotransfected. Also, TMBr-3 and TM5NM1 differently
regulated the access of actin to its binding partners, such as
myosin and actin depolymerizing factor (ADF)/cofilin
[Bryce et al., 2003]. Altogether, the above results indicate
that these tropomyosin isoforms can define functionally dis-
tinct microfilament compartments.
Despite the extensive studies on tropomyosins, the physi-
cochemical properties and the molecular bases of the
isoform-specific functional differences are not well under-
stood. To better understand the cellular functioning of
TMBr-3 and TM5NM1 isoforms we aimed to characterize
their interactions with actin using biophysical and biochem-
ical approaches. Here we report the purification of the
recombinant TMBr-3 and TM5NM1 and the in vitro char-
acterization of their interactions with actin. We showed that
both isoforms bind actin filaments, however, the affinity of
TM5NM1 was much higher than that of TMBr-3. Both
tropomyosins have minor effect on actin polymerization;
TMBr-3 slightly decreased the rate of actin assembly, while
TM5NM1 slightly increased it. Consistently with the
higher affinity of TM5NM1 it inhibited actin filament dis-
assembly more effectively than TMBr-3. TM5NM1 inhib-
ited the Actin-related protein (Arp) 2/3 complex-mediated
actin assembly as detected for other previously studied tro-
pomyosins. Interestingly, TMBr-3 by not influencing the
Arp2/3 complex-mediated polymerization seems to be a
unique tropomyosin isoform, since so far it is the only
known tropomyosin supporting the activity of the Arp2/3
complex.
Results
Expression and Purification of TMBr-3 and
TM5NM1
We produced the TMBr-3 and TM5NM1 tropomyosin
isoforms as recombinant proteins in sufficient amount for
in vitro characterization of their interactions with actin.
Binding of tropomyosin isoforms to actin filaments can
exhibit a high degree of cooperativity, in which the forma-
tion of so called head-to-tail interactions between the N-,
and C-termini of neighboring tropomyosin molecules are
crucial. Minor modifications in the amino acid sequence
can affect actin binding and consequently the function of
tropomyosins. Therefore, we aimed to purify TMBr-3 and
TM5NM1 isoforms as recombinant proteins without any
excess amino acids of the original sequences. The full length
coding sequences of the corresponding mouse tropomyosin
isoforms were used for protein production (Fig. 1B).
TMBr-3 consists of 738 nucleotides (including the stop
codon) encoding 245 amino acids. Compared with other
GenBank sequences it contains a M91T amino acid change.
TM5NM1 is 747 base pair long encoding 248 amino acids,
carrying an E230G amino acid change. The significance of
these alterations is not known. The full coding sequences of
mouse TMBr-3 and TM5NM1 were cloned into pET28a
plasmid in E. coli and expressed in Luria-Broth medium.
The His-tagged proteins were purified from the bacterial
pellet using Ni-NTA and hydroxyapatite affinity. The His-
tag was removed by TEV protease digestion. According to
our cloning scheme, the TEV protease cleavage occurred
directly before the first methionine of the protein sequence.
The average yield of the purified protein was 3–5 mg/L of
E. coli culture. The recombinant TMBr-3 and TM5NM1
proteins produced a band on Coomassie-stained SDS-
PAGE gel with an apparent molecular mass of approxi-
mately 37 and 31 kDa, respectively (Fig. 1C). The molecu-
lar mass of TMBr-3 and TM5NM1 estimated from the
sequence were 28.313 and 28.948 kDa, respectively (Prot-
param). Mass spectrometry gave very similar results to the
sequence analysis [28.301 and 28.949 kDa for TMBr-3
and TM5NM1, respectively (data not shown)].
Binding of TMBr-3 and TM5NM1 to Actin
Filaments
To test the ability of recombinant TMBr-3 and TM5NM1
to bind actin filaments (F-actin) cosedimentation assays were
performed. Increasing amounts of TMBr-3 or TM5NM1
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were incubated with F-actin (5 mM) overnight and the sam-
ples were pelleted. The SDS-PAGE analysis revealed that the
amount of these tropomyosin isoforms cosedimented with
F-actin was increased in a concentration dependent manner,
suggesting that both TMBr-3 and TM5NM1 bound to actin
filaments (Fig.F2 2A). As controls, TMBr-3 and TM5NM1 at
different concentrations were also centrifuged in the absence
of F-actin. We found that a small amount of tropomyosin
appeared in the pellet even without F-actin (data are not
shown). The amounts of the pelleted tropomyosin in the
absence of actin were quantified at each concentration and
used for the correction of the TMBr-3 and TM5NM1 bands
obtained with the actin-containing samples. The corrected
TM:F-actin band intensity ratios were plotted as a function
of tropomyosin concentration (Fig. 2B). Hyperbola fit
(Eq. 1) to the data gave dissociation equilibrium constants
(Kd) of 3.56 0.9 mM and 0.16 0.1 mM for the binding of
TMBr-3 and TM5NM1 to F-actin, respectively. Although
the latter estimate clearly indicates a very tight binding affin-
ity, relatively large errors attributed to the calculated mean.
The large error appears probably due to the very tight bind-
ing and relatively large applied protein concentrations.
To overcome this problem one should decrease the actin
concentration in similar experiments. In this work we
avoided doing this because they would cause a much larger
relative contribution from monomeric actin to the actin
pool.
Effects of TMBr-3 and TM5NM1 on Actin
Filament Assembly
Tropomyosins can affect actin filament assembly in an
isoform-dependent manner. Muscle tropomyosins, such as
recombinant striated muscle and tissue purified rabbit skel-
etal ab TM, slowed down actin polymerization, presum-
ably by their protective effects against the spontaneous
mechanical breakage of the actin filaments producing less
free ends for the polymerization [Lal and Korn, 1986;
Wawro et al., 2007]. In contrast, nonmuscle TM5a and
TM2 enhanced actin polymerization by 30–40%, sug-
gesting a specific effect on barbed end dynamics [Wawro
et al., 2007]. To study the effect of TMBr-3 and
TM5NM1 on the kinetics of actin assembly, polymeriza-
tion assays were performed. To quantify our observations
the polymerization rates were derived by linear fitting to
the 0.45–0.55 range of the normalized pyrene traces. In
agreement with previous observations, we found that 6 mM
skeletal muscle tropomyosin (skTM) slowed down the
assembly of 5 mM actin by 60% (Fig. F33). Note that con-
sidering the affinity of skTM to actin (Kd5 0.5 mM) the
6 mM skTM saturated the binding sites on actin in equilib-
rium. 40 mM TMBr-3 and 17 mM TM5NM1 (more than
10-fold greater than the corresponding Kd values) had only
minor effect on actin polymerization (Fig. 3). Similarly to
skTM, TMBr-3 reduced the rate of actin assembly. While
TM5NM1 slightly enhanced actin assembly rate.
Effects of TMBr-3 and TM5NM1 on Actin
Filament Disassembly
Tropomyosins can inhibit the disassembly of actin filaments
by their structural stabilization effect [Broschat, 1990]. To
Fig. 2. (A) TMBr-3 (upper panel) or TM5NM1 (lower panel)
at different concentrations in the presence of 5 mM actin was
sedimented, and analyzed on SDS-PAGE by densitometric eval-
uation. TMBr-3 concentrations are as follows: 0, 2, 4, 6, 8, 12,
30 and 40 mM, for TM5NM1 the concentrations are 0, 1, 2, 3,
5, 8, 12, 20, 30 mM. (B) Stoichiometric ratio of tropomyosin
to actin in the pellet (S) was plotted as the function of the total
tropomyosin concentration (TMBr-3: squares, TM5NM1:
circles). Dashed line shows the hyperbola fit to the data using
Eq. (1). Data were derived from three independent experiments
and the errors are given as standard deviations.
Fig. 3. Normalized rate of actin polymerization 5 mM G-actin
(5% pyrene labeled) in the absence and presence of different
tropomyosin isoforms, as indicated. The tropomyosin concen-
trations are as follows; 40 mM TMBr-3, 17 mM TM5NM1 and
6 mM skTM. Data were derived at least from three independent
experiments and the errors are given as standard deviations.
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study depolymerization, actin (2 mM, containing 50%
pyrene labeled actin) was first polymerized and then diluted
into polymerization buffer to reach final concentration of
50 nM. This strategy ensures that after dilution the actin
concentration is less than the critical concentration, which
results in actin filament disassembly dominated by barbed
end dynamics. The depolymerization kinetics of actin fila-
ments was followed by monitoring pyrene fluorescence. In
the absence of tropomyosin the transients showed single
decreasing phase (Fig.F4 4A upper panel; black curve). When
filaments were preincubated with either 10 mM skTM, 40
mM TMBr-3, or 40 mM TM5NM1 two phases were
observed (Fig. 4A upper panel). The first phase (for approx-
imately 50 s) showed slower depolymerization than in the
absence of tropomyosin. Then a second, faster phase
appeared. In these experiments the buffer to which actin
was diluted did not contain tropomyosin. Consequently,
after the dilution (403) the tropomyosin concentration has
decreased substantially. Due to the alteration of the condi-
tions a new equilibrium was established and most of the
tropomyosin dissociated from the filaments. We attribute
the first phases of the transients to the depolymerization of
actin filaments in the actin–tropomyosin complex, while
the second observed phase corresponded to the depolymer-
ization after the dissociation of tropomyosin. To confirm
this explanation we repeated the experiments by diluting
the actin filaments into buffers containing tropomyosin at
the same concentration as in the actin samples (10 mM
skTM or 40 mM TMBr-3). The transients obtained under
these conditions (Fig. 4A lower panel) were single phased
corroborating our conclusions regarding the effect of disso-
ciation of tropomyosin from actin. These observations
showed that all the investigated tropomyosins slowed down
the depolymerization of actin filaments, and also suggested
that dissociation of tropomyosin was slow and occurred on
the few tens of seconds time scale. The depolymerization
experiments were repeated at various tropomyosin concen-
trations. The first 50 sec of the transients were fitted with
linear functions and the slopes were used to estimate the
depolymerization rates. The data showed that these tropo-
myosin isoforms decreased the depolymerization rate in a
concentration dependent manner (Fig. 4B). However, skTM
and TM5NM1 had an approximately two-fold greater effect
on actin depolymerization than TMBr-3, in correlation with
the different affinities of these tropomyosins.
Effects of TMBr-3 and TM5NM1 on the Arp2/3
Complex-Catalyzed Actin Assembly
Previous biochemical studies revealed that some tropomyo-
sin isoforms inhibit the Arp2/3 complex-catalyzed actin
assembly [Blanchoin et al., 2001; Bugyi et al., 2010]. Cell
biological studies revealed that TMBr-3 and TM5NM1
had opposite effect on lamellipodia formation and cell






Fig. 4. (A) Depolymerization kinetics of 50 nM F-actin in the
absence (black line) or presence of TMBr-3 (40 mM; purple
line), TM5NM1 (40 mM; dark cyan line) or skTM (10 mM;
orange line). The upper panel shows the results obtained when
actin was diluted to buffer containing no tropomyosin. The
lower panel shows examples of data from experiments in which
the dilution was carried out into tropomyosin containing buffer.
Fifty nanomolar F-actin in the absence of tropomyosins (black
line) or in the presence of TMBr-3 (40 mM; purple line) or
skTM (10 mM; orange line). (B) Normalized depolymerization
rates of actin filaments (derived from data similar to those pre-
sented in Fig. 4A) as a function of tropomyosin concentration
([TM]). The results are shown for TMBr-3 (purple circles),
TM5NM1 (dark cyan circles) and skTM (orange circles). Data
were obtained from at least three independent experiments and
the errors are given as standard deviations.
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TMBr-3 and TM5NM1 on Arp2/3 complex activity poly-
merization assays were performed. We found that similarly
to skTM, TM5NM1 inhibited the VCA-Arp2/3 complex-
catalyzed actin assembly in a concentration-dependent
manner (Fig.F5 5B). At the highest TM5NM1 concentration
we applied the inhibition was 25% (Fig. 5B). Interest-
ingly, we found that TMBr-3 had no effect on Arp2/3
complex-catalyzed actin assembly (Fig. 5A).
Discussion
We produced TMBr-3 and TM5NM1 as recombinant pro-
teins in a nontagged form, without any excess amino acids
to the native sequence, because any extension at the poly-
peptide ends may cause unpredictable, even deleterious
effects [Bharadwaj et al., 2004]. We successfully purified
these tropomyosin isoforms in sufficient amount for in
vitro characterization of their interactions with actin. We
found that both TMBr-3 and TM5NM1 bind actin fila-
ments, however, their affinities for actin differ (Fig. 2).
TMBr-3 binds F-actin with approximately seven-fold lower
affinity (Kd5 3.486 0.92 mM) than skTM (Kd5 0.5 mM)
[Boussouf et al., 2007], while TM5NM1 has somewhat
tighter affinity (Kd5 0.106 0.16 mM) than skTM. These
differences in the binding strength are consistent with pre-
vious results, in showing that the affinity of tropomyosins
to actin strongly depends on the specific combination of
exons encoding the N-, and C-terminus of tropomyosins
[Moraczewska et al., 1999]. For the tropomyosin isoforms
studied in this paper, the 1b1d exon pair (Fig. 1A) is
expected to endow the TM5NM1 isoform with the highest
affinity, exons 1a9a with acetylation (for tissue purified
skTM) results in somewhat lower affinity, while the 1b9c
exon combination in TMBr-3 results in poor binding to
actin filaments. Our results support the view that the
N- and C- termini of tropomyosins are important determi-
nants of actin affinity by establishing the ability of tropo-
myosin isoforms to form end-to-end polymers along the
actin filament. The lower affinity of TMBr-3 binding to
actin filaments is also consistent with previous findings in
showing that brain isoforms isolated from tissue bind actin
with approximately 10-fold lower affinity than muscle iso-
forms [Broschat and Burgess, 1986]. It would also explain






Fig. 5. (A) Time courses of VCA-Arp2/3 complex catalyzed actin assembly monitored by the change in pyrene fluorescence in the
absence (black line) and presence of different tropomyosin isoforms, as indicated. Left panel: the TMBr-3 concentration is 30 mM
(magenta line). Right panel: the TM5NM1 concentrations are 5.1 mM (orange line), 10.2 mM (red line) and 17 mM (purple line). The
skTM concentration is 4.76 mM (dark yellow line). [G-actin]5 2.5 mM (5% pyrene labeled), [Arp2/3 complex]5 100 nM,
[VCA]5 200 nM. Light gray curve shows the kinetics of spontaneous actin assembly. (B) Normalized rate of VCA-Arp2/3 complex cata-
lyzed actin polymerization (derived from data similar to those presented in Fig. 5A) in the absence and presence of different tropomyosin
isoforms, as indicated. The tropomyosin concentrations are as follows; 40 mM TMBr-3, 17 mM TM5NM1, and 4.76 mM skTM.
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filaments by TMBr-3 cannot be reached by adding up to
10 mM of tropomyosin without troponin or myosin
[Moraczewska et al., 1999]. It should be also considered
that in nonmuscle cells tropomyosins associate exclusively
with nonmuscle b and g actin isoforms, rather than the
muscle specific a isoform that was used in our study [Wein-
berger et al., 1996]. Some isoform-dependent features can
establish specific actin and tropomyosin pairs with higher
binding affinity and preferential binding for optimal func-
tioning. As example, isoform-specific interactions were
already shown for profilin and formin isoforms [Neidt
et al., 2009]. The interaction of many actin-binding pro-
teins with monomeric or filamentous actin can be antago-
nistically or synergistically altered by the presence of other
proteins. As a relevant example, caldesmon—a calcium/
calmodulin regulated actin-binding protein—is known to
enhance the binding of low molecular weight tropomyosins
to actin [Yamashiro-Matsumura and Matsumura, 1988].
Since caldesmon is expressed in brain [Ueki et al., 1987],
we speculate that it may also promote the association of the
TMBr-3 isoforms to actin filaments.
SkTM at saturating amount slows down both actin
assembly and disassembly, by reducing the association and
dissociation rate constants of actin monomers to and from
the filaments (Figs. 3 and 4) [Lal and Korn, 1986; Broschat,
1990]. We found that TMBr-3 had a similar but smaller
effects on the rate of actin polymerization and depolymer-
ization (Figs. 3 and 4). This observation may be explained
by assuming that TMBr-3 decreases the rate constant for
the association of actin monomers to the ends of the fila-
ments to a lower extent than skTM. To corroborate this
assumption in cosedimentation assays we found that the
amount of actin in the supernatants were independent of
the TMBr-3 concentration (data not shown). Accordingly,
under polymerizing conditions the concentration of the
monomeric actin was the same in the absence and presence
of TMBr-3, indicating that TMBr-3 did not change the
critical concentration. Based on the unchanged critical con-
centration one would expect that TMBr-3 has the same
magnitude of effect on the association and dissociation rates
of the actin monomers. It was thus expected that TMBr-3
has the same effect on the association rate constant, which
correlates with the slight inhibition of actin assembly by
TMBr-3 (Fig. 3). In depolymerization experiments we
found evidence that the dissociation of the tropomyosin
from actin is slow, occurring within 50–100 sec. Thus, the
corresponding micromolar dissociation equilibrium con-
stant of the TM-actin complex suggest that tropomyosin
association to the filaments must also be slow falling into
the 104 M21 s21 range. In this case the binding of tropo-
myosin would occur on a second time-scale under our
experimental conditions, which is comparable with the rate
of actin filament growth. Therefore, in these measurements
we did not observe the full effect of TMBr-3 on the poly-
merization rate. In the depolymerization experiments actin
was preincubated with tropomyosin and the equilibrium
has been reached prior to the measurements. These consid-
erations can explain the small deviation of the experimental
data from the expectations based on the unchanged critical
concentration. Our data also implicated that TMBr-3 asso-
ciation to actin filaments is approximately 60-fold slower
than that of actin monomers. We found that TM5NM1
slightly stimulated actin assembly, while inhibited actin dis-
assembly at the same extent as skTM (Figs. 3 and 4). In
previous studies TM5a and TM2 isoforms behaved simi-
larly to TM5NM1, by increasing the polymerization rate
and inhibiting the depolymerization rate [Kostyukova and
Hitchcock-DeGregori, 2004; Wawro et al., 2007]. The C-
terminus of tropomyosin points toward the barbed end of
the actin filament, and this part is common for TM5NM1,
TM5a, and TM2 (exon 9d) but differ for skTM and
TMBr-3 (exon 9a or 9c, respectively) (Fig. 1A). While the
N-terminus facing toward the pointed end is the same for
skTM and TM2 (exons 1a2b) or TM5a, TMBr-3, and
TM5NM1 (exon 1b) (Fig. 1A). Although sequence and
hence structure-specific effects of the individual tropomyo-
sin termini can be assumed to have impact on actin fila-
ment end dynamics, no simple correlations seem to exist.
Considering the magnitude of the effects of different tropo-
myosins (TM5a/TM5NM1> skTM>TM2>TMBr-3)
this raises the possibility of the importance of actin affinity,
which in turn is determined by the head-to-tail interactions
of the tropomyosin ends [Moraczewska et al., 1999]. In
that respect the C-terminal exon 9c of TMBr-3 (shared
with TMBr-1 isoform) may have a significant concern on
the observed low binding strength and the moderate effects
on actin dynamics.
Similarly to all the previously studied tropomyosin iso-
forms (rabbit skTM, chicken striated muscle TM, TM5a,
and TM2) [Blanchoin et al., 2001; Bugyi, 2010], TM5NM1
inhibited the VCA-Arp2/3 complex catalyzed actin assembly
(Fig. 5). In contrast, we found that TMBr-3 did not have
any effect of the nucleation catalyzing activity of the VCA-
Arp2/3 complex machinery (Fig. 5). This is a unique feature
of TMBr-3, since so far this is the only tropomyosin isoform,
which allows Arp2/3 complex-dependent actin assembly.
The different effects of TMBr-3 and TM5NM1 on Arp2/3
complex-catalyzed actin assembly is in good agreement with
the observations from cellular studies. In B35 neuroepithelial
cells the expression of TMBr-3 or TM5NM1 cells resulted
in opposite effects on the leading edge region and lamellipo-
dia formation; excess TMBr-3 induced lamellipodia forma-
tion, while TM5NM1 decreased lamellipodia [Bryce et al.,
2003]. Also, in the brain the Arp2/3 complex machinery is
involved in the cytoskeletal organization of both post- and
presynaptic actin structures that can be also associated with
TMBr-3 [Had et al., 1994; Hotulainen et al., 2009; Hotulai-
nen and Hoogenraad, 2010; Spillane et al., 2011]. The
inhibitory effect of tropomyosins on Arp2/3 complex activity
is not attributed to differences in the ATP hydrolysis and
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phosphate release rate or debranching of daughter filaments,
it rather results from a competitive binding of the two pro-
teins to actin filaments [Blanchoin et al., 2001; Bugyi,
2010]. The exact molecular origin of the competitive bind-
ing between tropomyosin and Arp2/3 complex is not known.
Structural modeling revealed that the actin filament binding
sites of skTM and Arp2/3 complex partially overlap [Rouiller
et al., 2008], suggesting that the functional inhibition results
from sterical hindrance. No structural data are available for
TMBr-3 and TM5NM1 yet. However, previous studies
showed that the azimuthal equilibrium position of the tropo-
myosins around the actin filament can be isoform-specific
[Lehman et al., 2000]. Thus, the different effects of tropoy-
mosins on the activity of the Arp2/3 complex can originate
from the different positions of the different tropomyosin iso-
forms on actin filaments. This assumes that TMBr-3 occu-
pies positions on the actin filament different from those
tropomyosins that inhibit the activity of the Arp2/3 complex.
On the other hand, it cannot be excluded that differences in
the structural and kinetic features of the head-to-tail complex
formation, which is an important determinant of actin fila-
ment binding, can cause the differences in the effects of tro-
pomyosins on the interaction of actin with the Arp2/3
complex machinery. In conclusion, we propose that distinct
tropomyosin isoforms can have different kinetic and struc-
tural features and flexibility to occupy and maintain a charac-
teristic localization on the actin filament. This isoform
dependent nature of the tropomyosin-actin interactions is
also important in the competition for shared binding sites
with other actin-binding proteins, such as the Arp2/3 com-
plex, which plays essential roles in the manifestation and reg-
ulation of the biological functions of tropomyosins.
Although more information will be required to under-
stand the exact roles of these tropomyosins in nonmuscle
cells, the current observations suggest that their functions
differ substantially. In future studies it would also be impor-
tant to investigate whether the presence of other actin-
regulatory proteins, such as caldesmon, ADF/cofilins and
myosins and b and g actin isoforms have an impact on the
interaction of the TMBr-3 and TM5NM1 with actin.
Materials and Methods
Molecular Cloning and Protein Preparation
The mouse TMBr-3 tropomyosin construct was generated
from a previously cloned sequence in pET28a plasmids
containing an N-terminal FXa protease recognition site.
TM5NM1 was cloned de novo from total mRNA starting
with reverse transcription and PCR to produce cDNA. We
designed target-specific PCR primers: the forward primer
was 50- TAT TTT CAG ATG GCG GGG AGT AGC
TCG CT -30 and the reverse primer was 50- TCT AAG
CTT TTA ATC CTC ATT CAG GGC CA -30 for
TMBr-3, and 50- TAT TTT CAG atg gcc ggg acc acc acc
atc -30 and 50- TCT AAG CTT TTA CAT CTC GTT
CAG GT -30 for TM5NM1. The introduction of a HindIII
restriction endonuclease site is underlined. The thermal
cycler conditions were as follows: 95C for 5 min, 38 cycles
of 95C for 30 s denaturation, 50C for 1 min annealing,
and 72C for 1 min synthesis, then 72C for 5 min. For
TM5NM1 we applied 10 cycles at 42C for 1 min and 30
cycles at 51C for 1 min as annealing. In a second round
PCR an EcoRI restriction endonuclease (underlined) and a
ProTEV protease site (double underlined) were tailored N-
terminal to the coding sequence using the 50- CTC GAA
TTC GAA AAC CTG TAT TTT CAG ATG -30 forward
primer and the above reverse primers. The thermal cycler
conditions were: 95C for 5 min, 40 cycles of 95C for 30
sec denaturation, 58C for 1 min annealing, and 72C for
1 min synthesis, then 72C for 5 min. The PCR product
was cloned into 6xHis/pET28a expression plasmid (Nova-
Gen) between the EcoRI and HindIII restriction sites. The
recombinant protein was expressed in E. coli BL21 (DE3)
cells using 30 mg/ml kanamycin as selection antibiotics. A
preculture in 5 ml was prepared over night at 37C, and
used to inoculate 3L Luria Broth medium. The cells were
grown to OD600 0.6–0.8 at 37
C and induced by 1 mM
IPTG (Sigma) for 4 h. Bacterial pellet was resuspended in
lysis buffer (50 mM NaH2PO4 buffer pH 8.0, 500 mM
NaCl), containing 2 mg/ml DNase, 5 mM MgCl2, 13
complete protease inhibitor mix (Sigma), and 0.2 mM
PMSF, lyzed by five cycles of freeze-thaw and sonication
(5 3 1 min), then centrifuged (6000 3 g for 15 min at
4C, Sorvall, T-1250 rotor). The supernatant was loaded to
Ni-NTA chelating column (QIAGEN) equilibrated with
lysis buffer, and eluted with 5, 10, 20, 40, and 250 mM
imidazole (Sigma) in lysis buffer. The peak fractions were
pooled and dialyzed against hydroxyapatite column buffer
(1 mM Na-phosphate buffer pH 7.0, 1 M KCl, 2.5 mM
DTT). The sample was loaded on a hydroxyapatite CHT
column (Bio-Rad), and eluted with 300 mM Na-phosphate
buffer, pH 7.0, 1 M KCl and 2.5 mM DTT. The peak frac-
tions were pooled and dialyzed against storage buffer
(5 mM Tris pH 7.5, 100 mM KCl, 1 mM DTT). The His-
tag was cleaved by TEV protease at 37C, adjusting the
amount of protease and the time of incubation empirically.
The digested protein was again purified on a Ni-NTA col-
umn to remove the His-tag and the TEV protease. The
flowthrough was concentrated, ultracentrifuged (676,000
3 g for 20 min at 4C Beckman-Coulter, MLA-130 rotor),
and the concentration was measured using a BCA kit
(Sigma). Protein preparations were stored at 0C in 5 mM
Tris pH 7.5, 100 mM KCl, and 1 mM DTT.
TEV protease was purified using a 63 His-tag pET24
(TEV-235) plasmid construction (a kind gift of H€useyin
Besir EMBL) in E.coli BL21 DE3 cells. Freshly transformed
bacteria were plated on LB-agar containing 30 mg/ml kana-
mycin, and 60 ml preculture was grown over night at
37C. It was then used in 2% to inoculate 3 l LB medium
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grown to OD600 0.6–0.8 at 37
C. The temperature was
reduced to 30C for 45 min, and expression was induced
by adding 1 mM IPTG for 4 h at 30C. Bacterial pellet
was resuspended in lysis buffer (50 mM Na-phosphate
buffer pH 8.0, 100 mM NaCl, 25 mM imidazole, 10%
glycerol) containing 2 mg/ml DNase, 5 mM MgCl2, 13
complete protease inhibitor mix (Sigma), 0.2 mM PMSF
and 500 mg/ml lysozyme. It was incubated for 10 min at
RT and cells were further lyzed by sonication (6 3 25 sec).
The sample was centrifuged (100,000 3 g for 1 h at 4C,
Sorvall, T-1250 rotor), and the supernatant was loaded on
Ni-NTA column equilibrated with lysis buffer. The column
was incubated at 4C for 2 h then washed with 15 ml lysis
buffer and 10 ml elution buffer (50 mM Na-phosphate
buffer pH 8.0, 100 mM NaCl, 500 mM imidazole, 10%
glycerol). The latter fraction was dialyzed against IEX run-
ning buffer (50 mM Na-phosphate buffer pH 8.0, 100
mM NaCl, 1 mM EDTA, 1 mM DTT, 10% glycerol), and
further purified on anion exchange source 15Q column
with IEX elution buffer (50 mM Na-phosphate buffer pH
8.0, 1 M NaCl, 1 mM EDTA, 1 mM DTT, 10% glycerol).
The peak fractions were pooled and checked on SDS-
PAGE and ultracentrifuged (676,000 3 g for 20 min at
4C, Beckman-Coulter, MLA-130 rotor). The protein con-
centration was determined photometrically using E2805 1.19
ml*mg21*cm21. The final glycerol content was adjusted to
50% and the samples were stored at220C.
Actin was prepared from rabbit hind leg muscle [Spudich
and Watt, 1971] and gel filtered in a Superdex G75 (GE
Healthcare) column in buffer A (4 mM Tris pH 7.5, 0.2
mM ATP, 0.1 mM CaCl2, 0.5 mM MEA, 0.005% NaN3).
G-actin was stored on ice in buffer A until used. Before
polymerization CaCl2 was exchanged for MgCl2 with
EGTA.
Arp2/3 complex from bovine brain and recombinant
GST-tagged human VCA were purified as described previ-
ously [Egile et al., 1999].
skTM was purified from the remnants of the actin acetone
powder [Smillie, 1982], then applied to hydroxyapatite chro-
matography, and stored frozen in 5 mM Tris pH 7.8 and
1 mM DTT. For the fluorescent measurements actin was
labeled with pyrenyl-iodoacetamide as described previously
(pyrene, Invitrogen) [Kouyama and Mihashi, 1981]. The pro-
tein concentrations were measured photometrically using
E2805 1.11 ml*mg21*cm21 and E2905 0.63 ml*mg21*cm21
extinction coefficients for actin and E2805 0.3 ml*mg21*cm21
for skTM.
Co-Sedimentation Assays
Twenty micromolar Mg-G-actin in buffer A was polymerized
with 2 mMMgCl2 and 100 mM KCl, then the F-actin solu-
tion was diluted to 5 mM in the absence or presence of differ-
ent concentrations of tropomyosin in polymerization buffer
(buffer A supplemented with 2 mM MgCl2 and 100 mM
KCl (final concentrations)). Samples (60 ml) were incubated
over night at 4C, then pelleted (440,000 3 g for 30 min at
4oC, Beckman-Coulter, TLA-100 rotor). Pellets and super-
natants were separated and analyzed by SDS-PAGE
[Laemmli, 1970]. The protein bands on the gel were quanti-
fied using densitometry (GeneTools) after Coomassie stain-
ing. Control experiments showed that Coomassie stains actin
and these tropomyosin isoforms equally (data not shown).
The TM : actin ratio in the pellet was calculated and plotted
as a function of tropomyosin concentration. The data were
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where S is the TM: actin ratio in the pellet, Smax is the max-
imum value of S measured at saturating TM concentration,
[TM]0 and [A]0 are the total concentration of TM and actin
in the samples, respectively and Kd is the dissociation equi-
librium constant of the TM-F-actin complex.
Fluorescence Measurements
Fluorescence experiments were performed using a Perkin-
Elmer or a Jobin Yvon spectrofluorimeter (Horiba Scien-
tific). In all the experiments the actin-bound calcium was
replaced with magnesium by adding 0.2 mM EGTA and
0.05 mM MgCl2 (final concentrations) and incubating the
samples for 5–10 min at room temperature. Pyrene fluores-
cence was excited and the emission was detected at 365 nm
and 407 nm, respectively. Measurements were carried out
at 22C. When concentration dependence was measured
the total volume of tropomyosin and its storing buffer was
always kept constant and represented 40% of the total vol-
ume of the sample.
Polymerization Assays.
Five micromolar Mg-G-actin in buffer A (containing 5%
pyrene labeled actin) was polymerized in the presence of
2 mM MgCl2, 100 mM KCl (final concentrations) and dif-
ferent amounts of tropomyosin. Polymerization kinetics
was followed by measuring the changes in pyrene fluores-
cence in time. The fluorescence transients were normalized
and the polymerization rates were determined by fitting the
linear part (0.45–0.55) of the data. Average rates from at
least three independent measurements were calculated.
Depolymerization Assays.
Ten micromolar Mg-G-actin in buffer A (containing 50%
pyrene labeled actin) was polymerized over night by adding
J_ID: z7w Customer A_ID: CM21143 Cadmus Art: CM21143 Ed. Ref. No.: - Date: 20-September-13 Stage: Page: 9
ID: muralir Time: 21:08 I Path: N:/3b2/CM##/Vol00000/130055/APPFile/JW-CM##130055
CYTOSKELETON Neuron-Specific Tropomyosin Isoforms and Actin 9 
2 mM MgCl2 and 100 mM KCl (final concentrations) in
the absence or presence of tropomyosin. The F-actin solu-
tion was diluted to 50 nM into polymerization buffer.
Depolymerization kinetics was followed by measuring the
decrease in pyrene fluorescence in time. Depolymerization
rates were estimated by linear fitting the first 50 sec of the
pyrene transients. Average rates from at least three inde-
pendent measurements were calculated. Normalized depo-
lymerization rates were calculated as the ratio of the
depolymerization rate in the absence of tropomyosin to the
depolymerization rate in the presence of tropomyosin.
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